MDPI and ACS Style
Jastrzębska-Więsek, M.; Kotańska, M.; Grzeszczak, A.; Jaromin, A.; Walczak, M.; Partyka, A.; Gdula-Argasińska, J.; Smolik, M.; Zagórska, A.
The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia. Int. J. Mol. Sci. 2022, 23, 11452.
https://doi.org/10.3390/ijms231911452
AMA Style
Jastrzębska-Więsek M, Kotańska M, Grzeszczak A, Jaromin A, Walczak M, Partyka A, Gdula-Argasińska J, Smolik M, Zagórska A.
The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia. International Journal of Molecular Sciences. 2022; 23(19):11452.
https://doi.org/10.3390/ijms231911452
Chicago/Turabian Style
Jastrzębska-Więsek, Magdalena, Magdalena Kotańska, Aleksandra Grzeszczak, Anna Jaromin, Maria Walczak, Anna Partyka, Joanna Gdula-Argasińska, Magdalena Smolik, and Agnieszka Zagórska.
2022. "The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia" International Journal of Molecular Sciences 23, no. 19: 11452.
https://doi.org/10.3390/ijms231911452